Osteogenesis imperfecta type VII: an autosomal recessive form of brittle bone disease
- PMID: 12110406
- DOI: 10.1016/s8756-3282(02)00790-1
Osteogenesis imperfecta type VII: an autosomal recessive form of brittle bone disease
Abstract
Osteogenesis imperfecta (OI) is a heritable disease of bone with low bone mass and bone fragility. The disease is generally classified into four types based on clinical features and disease severity, although recently fifth and sixth forms have also been reported. Most forms of OI are autosomal dominant. Rarely, autosomal recessive disease has been described. We report the clinical, radiological, and histological features of four children (age 3.9-8.6 years at last follow-up; all girls) and four adults (age 28-33 years; two women) with a novel form of autosomal recessive OI living in an isolated First Nations community in northern Quebec. In keeping with the established numeric classification for OI forms, we have called this form of the disease OI type VII. The phenotype is moderate to severe, characterized by fractures at birth, bluish sclerae, early deformity of the lower extremities, coxa vara, and osteopenia. Rhizomelia is a prominent clinical feature. Histomorphometric analyses of iliac crest bone samples revealed findings similar to OI type I, with decreased cortical width and trabecular number, increased bone turnover, and preservation of the birefringent pattern of lamellar bone. The disease has subsequently been localized to chromosome 3p22-24.1, which is outside the loci for type I collagen genes. The underlying genetic basis for the disease remains to be determined.
Similar articles
-
Osteogenesis imperfecta type VI: a form of brittle bone disease with a mineralization defect.J Bone Miner Res. 2002 Jan;17(1):30-8. doi: 10.1359/jbmr.2002.17.1.30. J Bone Miner Res. 2002. PMID: 11771667
-
Type V osteogenesis imperfecta: a new form of brittle bone disease.J Bone Miner Res. 2000 Sep;15(9):1650-8. doi: 10.1359/jbmr.2000.15.9.1650. J Bone Miner Res. 2000. PMID: 10976985 Clinical Trial.
-
Recessive osteogenesis imperfecta: clinical, radiological, and molecular findings.Am J Med Genet C Semin Med Genet. 2012 Aug 15;160C(3):175-89. doi: 10.1002/ajmg.c.31334. Epub 2012 Jul 12. Am J Med Genet C Semin Med Genet. 2012. PMID: 22791419 Review.
-
Novel variant in Sp7/Osx associated with recessive osteogenesis imperfecta with bone fragility and hearing impairment.Bone. 2018 May;110:66-75. doi: 10.1016/j.bone.2018.01.031. Epub 2018 Jan 31. Bone. 2018. PMID: 29382611
-
Classification of osteogenesis imperfecta.Wien Med Wochenschr. 2015 Jul;165(13-14):264-70. doi: 10.1007/s10354-015-0368-3. Epub 2015 Jul 25. Wien Med Wochenschr. 2015. PMID: 26208476 Review.
Cited by
-
Dental and craniofacial defects in the Crtap-/- mouse model of osteogenesis imperfecta type VII.Dev Dyn. 2020 Jul;249(7):884-897. doi: 10.1002/dvdy.166. Epub 2020 Mar 12. Dev Dyn. 2020. PMID: 32133710 Free PMC article.
-
Prolyl 3-hydroxylase 1 deficiency causes a recessive metabolic bone disorder resembling lethal/severe osteogenesis imperfecta.Nat Genet. 2007 Mar;39(3):359-65. doi: 10.1038/ng1968. Epub 2007 Feb 4. Nat Genet. 2007. PMID: 17277775 Free PMC article.
-
CRTAP-Null Osteoblasts Have Increased Proliferation, Protein Secretion, and Skeletal Morphogenesis Gene Expression with Downregulation of Cellular Adhesion.Cells. 2025 Mar 31;14(7):518. doi: 10.3390/cells14070518. Cells. 2025. PMID: 40214472 Free PMC article.
-
New genes in bone development: what's new in osteogenesis imperfecta.J Clin Endocrinol Metab. 2013 Aug;98(8):3095-103. doi: 10.1210/jc.2013-1505. Epub 2013 Jun 14. J Clin Endocrinol Metab. 2013. PMID: 23771926 Free PMC article. Review.
-
Surgical treatment in Osteogenesis Imperfecta - 10 years experience.J Med Life. 2013 Jun 15;6(2):205-13. Epub 2013 Jun 25. J Med Life. 2013. PMID: 23904885 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical